HELSINKI — Health officials in Finland announced the country will keep using the AstraZeneca vaccine and only administer it to people age 65 and over as it has done since late March.

Finland temporarily suspended the AstraZeneca vaccine for more than a week on March 19 after brain blood clots were diagnosed in two individuals who had received the jab. It continued administering it later the same month to people 65 and over.

“They have not been found to have an increased risk of developing very rare blood clotting problems after vaccination,” said Chief Physician Hanna Nohyek at the Finnish National Institute for Health and Welfare.

Three blood clot cases have been reported in Finland, a nation of 5.5 million, with the nearly 250,000 people receiving the shot by AstraZeneca.

All three cases were diagnosed in patients under 65, health officials say.